Skip to main content
Erschienen in: Inflammation 5/2014

01.10.2014

CRP Gene (1059G>C) Polymorphism and Its Plasma Levels in Ischemic Stroke and Hemorrhagic Stroke in a South Indian Population

verfasst von: Satrupa Das, Sitara Roy, Subhash Kaul, Akka Jyothy, Anjana Munshi

Erschienen in: Inflammation | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

In the present study, we evaluated the association of 1059G>C polymorphism in C-reactive protein (CRP) gene with the risk of ischemic and hemorrhagic strokes. We did not find a significant association of this polymorphism with stroke. However, 2 % of mutants were observed in hemorrhagic stroke patients with a 0.01 frequency for the C allele. We also estimated the high-sensitivity C-reactive protein (hsCRP) levels in hemorrhagic stroke and compared the levels with our already published data on ischemic stroke. The hsCRP level in hemorrhagic stroke was found to be significantly elevated in comparison with that in controls (p < 0.001). However, there was no difference in the mean value of hsCRP levels between types of stroke. In conclusion, the G>C polymorphism in the promoter region of the CRP gene is not abundant in the population and cannot be connected with different hsCRP levels and stroke prediction. The CRP level is a useful marker in stroke, but cannot help in differentiating between types of stroke.
Literatur
1.
Zurück zum Zitat Ross, R. 1999. Atherosclerosis—An inflammatory disease. New England Journal of Medicine 340: 115–126.PubMedCrossRef Ross, R. 1999. Atherosclerosis—An inflammatory disease. New England Journal of Medicine 340: 115–126.PubMedCrossRef
2.
Zurück zum Zitat Stoll, G., and M. Bendszus. 2006. Inflammation and atherosclerosis: Novel insights into plaque formation and destabilization. Stroke 37: 1923–1932.PubMedCrossRef Stoll, G., and M. Bendszus. 2006. Inflammation and atherosclerosis: Novel insights into plaque formation and destabilization. Stroke 37: 1923–1932.PubMedCrossRef
3.
Zurück zum Zitat Nadamuni, S. 2002. Researchers identify stroke subtypes in India. Lancet 359: 500. Nadamuni, S. 2002. Researchers identify stroke subtypes in India. Lancet 359: 500.
4.
Zurück zum Zitat O’Donnell, M.J., D. Xavier, L. Liu, H. Zhang, S.L. Chin, P. Rao-Melacini, S. Rangarajan, S. Islam, P. Pais, and M.J. McQueen. 2010. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case–control study. Lancet 376: 112–123.PubMedCrossRef O’Donnell, M.J., D. Xavier, L. Liu, H. Zhang, S.L. Chin, P. Rao-Melacini, S. Rangarajan, S. Islam, P. Pais, and M.J. McQueen. 2010. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case–control study. Lancet 376: 112–123.PubMedCrossRef
5.
Zurück zum Zitat Kaul, S., and A. Munshi. 2012. Genetics of ischemic stroke: Indian perspective. Neurology India 60(5): 498–503.PubMedCrossRef Kaul, S., and A. Munshi. 2012. Genetics of ischemic stroke: Indian perspective. Neurology India 60(5): 498–503.PubMedCrossRef
6.
Zurück zum Zitat Flex, A., E. Gaetani, P. Papaleo, G. Straface, A.S. Proia, G. Pecorini, et al. 2004. Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke 35: 2270–2275.PubMedCrossRef Flex, A., E. Gaetani, P. Papaleo, G. Straface, A.S. Proia, G. Pecorini, et al. 2004. Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke 35: 2270–2275.PubMedCrossRef
7.
Zurück zum Zitat Gabay, C., and I. Kushner. 1999. Acute-phase proteins and other systemic responses to inflammation. New England Journal of Medicine 340: 448–454.PubMedCrossRef Gabay, C., and I. Kushner. 1999. Acute-phase proteins and other systemic responses to inflammation. New England Journal of Medicine 340: 448–454.PubMedCrossRef
8.
Zurück zum Zitat Pasceri, V., J.T. Willerson, and E.T. Yeh. 2000. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102: 2165–2168.PubMedCrossRef Pasceri, V., J.T. Willerson, and E.T. Yeh. 2000. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102: 2165–2168.PubMedCrossRef
9.
Zurück zum Zitat Calabro, P., J.T. Willerson, and E.T. Yeh. 2003. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108: 1930–1932.PubMedCrossRef Calabro, P., J.T. Willerson, and E.T. Yeh. 2003. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108: 1930–1932.PubMedCrossRef
10.
Zurück zum Zitat Volanakis, J.E. 2001. Human C-reactive protein: Expression, structure, and function. Molecular Immunology 38: 189–197.PubMedCrossRef Volanakis, J.E. 2001. Human C-reactive protein: Expression, structure, and function. Molecular Immunology 38: 189–197.PubMedCrossRef
11.
Zurück zum Zitat Meier-Ewert, H.K., P.M. Ridker, N. Rifai, N. Price, D.F. Dinges, and J.M. Mullington. 2001. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clinical Chemistry 47: 426–430.PubMed Meier-Ewert, H.K., P.M. Ridker, N. Rifai, N. Price, D.F. Dinges, and J.M. Mullington. 2001. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clinical Chemistry 47: 426–430.PubMed
12.
Zurück zum Zitat Bassuk, S.S., N. Rifai, and P.M. Ridker. 2004. High-sensitivity C-reactive protein: Clinical importance. Current Problems in Cardiology 29: 439–493.PubMed Bassuk, S.S., N. Rifai, and P.M. Ridker. 2004. High-sensitivity C-reactive protein: Clinical importance. Current Problems in Cardiology 29: 439–493.PubMed
13.
Zurück zum Zitat Pai, J.K., K.J. Mukamal, K.M. Rexrode, and E.B. Rimm. 2008. C-reactive protein (CRP) gene polymorphisms, CRP levels and risk of incident coronary heart disease in two nested case-control studies. PLoS ONE 3: e1395.PubMedCrossRefPubMedCentral Pai, J.K., K.J. Mukamal, K.M. Rexrode, and E.B. Rimm. 2008. C-reactive protein (CRP) gene polymorphisms, CRP levels and risk of incident coronary heart disease in two nested case-control studies. PLoS ONE 3: e1395.PubMedCrossRefPubMedCentral
14.
Zurück zum Zitat Brull, D.J., N. Serrano, F. Zito, L. Jones, H.E. Montgomery, A. Rumley, P. Sharma, G.D. Lowe, M.J. World, S.E. Humphries, and A.D. Hingorani. 2003. Human CRP gene polymorphism influences CRP levels: Implications for the prediction and pathogenesis of coronary heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology 23: 2063–2069.PubMedCrossRef Brull, D.J., N. Serrano, F. Zito, L. Jones, H.E. Montgomery, A. Rumley, P. Sharma, G.D. Lowe, M.J. World, S.E. Humphries, and A.D. Hingorani. 2003. Human CRP gene polymorphism influences CRP levels: Implications for the prediction and pathogenesis of coronary heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology 23: 2063–2069.PubMedCrossRef
15.
Zurück zum Zitat Claes, L., J. Katarina, B. Christian, N. Staffan, J. Christina, and L. Per. 2006. Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke 37: 2018–2023.CrossRef Claes, L., J. Katarina, B. Christian, N. Staffan, J. Christina, and L. Per. 2006. Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke 37: 2018–2023.CrossRef
16.
Zurück zum Zitat Qi, W., D. Hu, T. Jia-rong, Z. Lan, X. Yu-jun, Y. Jiang-tao, W. Wei, H. Ru-tai, W. Cong-yi, and W. Dao-wen. 2009. C-reactive protein polymorphisms and genetic susceptibility to ischemic stroke and hemorrhagic stroke in the Chinese Han population. Acta Pharmacologica Sinica 30(3): 291–298.CrossRef Qi, W., D. Hu, T. Jia-rong, Z. Lan, X. Yu-jun, Y. Jiang-tao, W. Wei, H. Ru-tai, W. Cong-yi, and W. Dao-wen. 2009. C-reactive protein polymorphisms and genetic susceptibility to ischemic stroke and hemorrhagic stroke in the Chinese Han population. Acta Pharmacologica Sinica 30(3): 291–298.CrossRef
17.
Zurück zum Zitat Munshi, A., S. Shehnaz, S. Kaul, B. Pulla Reddy, S. Alladi, and A. Jyothy. 2008. Angiotensin converting enzyme insertion/deletion polymorphism and the risk of ischemic stroke in a South Indian population. Journal of Neurological Sciences 272: 132–135.CrossRef Munshi, A., S. Shehnaz, S. Kaul, B. Pulla Reddy, S. Alladi, and A. Jyothy. 2008. Angiotensin converting enzyme insertion/deletion polymorphism and the risk of ischemic stroke in a South Indian population. Journal of Neurological Sciences 272: 132–135.CrossRef
18.
Zurück zum Zitat Rajeshwar, K., S. Kaul, A. Al-Hazzani, M.S. Babu, N. Balakrishna, V. Sharma, et al. 2012. C-reactive protein and nitric oxide levels in ischemic stroke and its subtypes: Correlation with clinical outcome. Inflammation 35(3): 978–984.PubMedCrossRef Rajeshwar, K., S. Kaul, A. Al-Hazzani, M.S. Babu, N. Balakrishna, V. Sharma, et al. 2012. C-reactive protein and nitric oxide levels in ischemic stroke and its subtypes: Correlation with clinical outcome. Inflammation 35(3): 978–984.PubMedCrossRef
19.
Zurück zum Zitat Bonow, R.O., L.A. Smaha, S.C. Smith Jr., G.A. Mensah, and C. Lenfant. 2002. World Heart Day 2002: The international burden of cardiovascular disease: Responding to the emerging global epidemic. Circulation 106: 1602–1605.PubMedCrossRef Bonow, R.O., L.A. Smaha, S.C. Smith Jr., G.A. Mensah, and C. Lenfant. 2002. World Heart Day 2002: The international burden of cardiovascular disease: Responding to the emerging global epidemic. Circulation 106: 1602–1605.PubMedCrossRef
20.
Zurück zum Zitat Feigin, V.L. 2005. Stroke epidemiology in the measurements developing world. Lancet 365: 2160–2161.PubMedCrossRef Feigin, V.L. 2005. Stroke epidemiology in the measurements developing world. Lancet 365: 2160–2161.PubMedCrossRef
21.
Zurück zum Zitat Ridker, P.M., E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto, and J.J. Kastelein. 2008. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. New England Journal of Medicine 359: 2195–2207.PubMedCrossRef Ridker, P.M., E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto, and J.J. Kastelein. 2008. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. New England Journal of Medicine 359: 2195–2207.PubMedCrossRef
22.
Zurück zum Zitat Feigin, V.L., C.M. Lawes, D.A. Bennett, and C.S. Anderson. 2003. Stroke epidemiology: A review of population-based studies of incidence, prevalence and case-fatality in the late 20th century. Lancet Neurology 2(1): 43–53.CrossRef Feigin, V.L., C.M. Lawes, D.A. Bennett, and C.S. Anderson. 2003. Stroke epidemiology: A review of population-based studies of incidence, prevalence and case-fatality in the late 20th century. Lancet Neurology 2(1): 43–53.CrossRef
23.
Zurück zum Zitat Castillo, J., and I. Rodriguez. 2004. Biochemical changes and inflammatory response as markers for brain ischaemia: Molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovascular Diseases 17(suppl 1): 7–18.PubMedCrossRef Castillo, J., and I. Rodriguez. 2004. Biochemical changes and inflammatory response as markers for brain ischaemia: Molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovascular Diseases 17(suppl 1): 7–18.PubMedCrossRef
24.
Zurück zum Zitat Morita, A., T. Nakayama, and M. Soma. 2006. Association study between C-reactive protein genes and ischemic stroke in Japanese subjects. American Journal of Hypertension 19: 593–600.PubMedCrossRef Morita, A., T. Nakayama, and M. Soma. 2006. Association study between C-reactive protein genes and ischemic stroke in Japanese subjects. American Journal of Hypertension 19: 593–600.PubMedCrossRef
25.
Zurück zum Zitat Roudbary, S.A., F. Saadat, K. Forghanparast, and R. Sohrabnejad. 2011. Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke. Acta Medica Iranica 49(3): 149–152.PubMed Roudbary, S.A., F. Saadat, K. Forghanparast, and R. Sohrabnejad. 2011. Serum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke. Acta Medica Iranica 49(3): 149–152.PubMed
26.
Zurück zum Zitat Rajput, M.R., M.A. Lakhair, M.A. Shaikh, M.S. Rind, and Bano R. Zafarullah. 2011. C-reactive protein (CRP) and other risk factors in acute ischemic stroke patients. Journal of Liaquat University of Medical and Health Sciences (JLUMHS) 10(3): 131–133. Rajput, M.R., M.A. Lakhair, M.A. Shaikh, M.S. Rind, and Bano R. Zafarullah. 2011. C-reactive protein (CRP) and other risk factors in acute ischemic stroke patients. Journal of Liaquat University of Medical and Health Sciences (JLUMHS) 10(3): 131–133.
27.
Zurück zum Zitat Napoli, M.D., F. Papa, and V. Bocola. 2001. C-reactive protein in ischemic stroke: An independent prognostic factor. Stroke 32(4): 917–924.PubMedCrossRef Napoli, M.D., F. Papa, and V. Bocola. 2001. C-reactive protein in ischemic stroke: An independent prognostic factor. Stroke 32(4): 917–924.PubMedCrossRef
28.
Zurück zum Zitat Muir, K.W., C.J. Weir, W. Alwan, I.B. Squire, and K.R. Lees. 1999. C-reactive protein and outcome after ischemic stroke. Stroke 30(5): 981–985.PubMedCrossRef Muir, K.W., C.J. Weir, W. Alwan, I.B. Squire, and K.R. Lees. 1999. C-reactive protein and outcome after ischemic stroke. Stroke 30(5): 981–985.PubMedCrossRef
29.
Zurück zum Zitat Chaudhuri, J.R., R.M. Kandadai, U. Matapathi, S. Alluri, B. Banda, and V.C.S. Bandaru. 2013. High sensitivity C-reactive protein levels in acute ischemic stroke and subtypes: A study from a tertiary care center. Iranian Journal of Neurology 12(3): 92–97.PubMedPubMedCentral Chaudhuri, J.R., R.M. Kandadai, U. Matapathi, S. Alluri, B. Banda, and V.C.S. Bandaru. 2013. High sensitivity C-reactive protein levels in acute ischemic stroke and subtypes: A study from a tertiary care center. Iranian Journal of Neurology 12(3): 92–97.PubMedPubMedCentral
30.
Zurück zum Zitat Den Hertog, H.M., J.A. Van Rossum, H.B. Van der Worp, H.M. Van Gemert, R. De Jonge, P.J. Koudstaal, et al. 2009. C-reactive protein in the very early phase of acute ischemic stroke: Association with poor outcome and death. Journal of Neurology 256(12): 2003–2008.CrossRef Den Hertog, H.M., J.A. Van Rossum, H.B. Van der Worp, H.M. Van Gemert, R. De Jonge, P.J. Koudstaal, et al. 2009. C-reactive protein in the very early phase of acute ischemic stroke: Association with poor outcome and death. Journal of Neurology 256(12): 2003–2008.CrossRef
31.
Zurück zum Zitat Carlson, Christopher S., Shelley Force Aldred, Philip K. Lee, Russell P. Tracy, Stephen M. Schwartz, Mark Rieder, O. Kiang Liu, Dale Williams, E. Carlos Iribarren, Cora Lewis, Myriam Fornage, Eric Boerwinkle, Myron Gross, Cashell Jaquish, A. Nickerson Deborah, Richard M. Myers, David S. Siscovick, and Alexander P. Reiner. 2005. Polymorphisms within the C-reactiveprotein (CRP) promoter region are associated with plasma CRP levels. American Journal of Human Genetics 77: 64–77.PubMedCrossRefPubMedCentral Carlson, Christopher S., Shelley Force Aldred, Philip K. Lee, Russell P. Tracy, Stephen M. Schwartz, Mark Rieder, O. Kiang Liu, Dale Williams, E. Carlos Iribarren, Cora Lewis, Myriam Fornage, Eric Boerwinkle, Myron Gross, Cashell Jaquish, A. Nickerson Deborah, Richard M. Myers, David S. Siscovick, and Alexander P. Reiner. 2005. Polymorphisms within the C-reactiveprotein (CRP) promoter region are associated with plasma CRP levels. American Journal of Human Genetics 77: 64–77.PubMedCrossRefPubMedCentral
32.
Zurück zum Zitat Zee, R.Y.L., and P.M. Ridker. 2002. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 162: 217–219.PubMedCrossRef Zee, R.Y.L., and P.M. Ridker. 2002. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 162: 217–219.PubMedCrossRef
33.
Zurück zum Zitat Zacho, J., A. Tybjaerg-Hansen, J.S. Jensen, P. Grande, H. Sillesen, and B.G. Nordestgaard. 2008. Genetically elevated C-reactive protein and ischemic vascular disease. New England Journal of Medicine 359(18): 1897–1908.PubMedCrossRef Zacho, J., A. Tybjaerg-Hansen, J.S. Jensen, P. Grande, H. Sillesen, and B.G. Nordestgaard. 2008. Genetically elevated C-reactive protein and ischemic vascular disease. New England Journal of Medicine 359(18): 1897–1908.PubMedCrossRef
34.
Zurück zum Zitat Napoli, M.D., M.S.V. Elkind, D.A. Godoy, P. Singh, F. Papa, and A. Popa-Wagner. 2011. Role of C-reactive protein in cerebrovascular disease. Expert Review of Cardiovascular Therapy 9(12): 1565–1584.PubMedCrossRef Napoli, M.D., M.S.V. Elkind, D.A. Godoy, P. Singh, F. Papa, and A. Popa-Wagner. 2011. Role of C-reactive protein in cerebrovascular disease. Expert Review of Cardiovascular Therapy 9(12): 1565–1584.PubMedCrossRef
Metadaten
Titel
CRP Gene (1059G>C) Polymorphism and Its Plasma Levels in Ischemic Stroke and Hemorrhagic Stroke in a South Indian Population
verfasst von
Satrupa Das
Sitara Roy
Subhash Kaul
Akka Jyothy
Anjana Munshi
Publikationsdatum
01.10.2014
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 5/2014
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-014-9897-y

Weitere Artikel der Ausgabe 5/2014

Inflammation 5/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.